Ophthalmology

In its second acquisition of the month, Shire acquires ophthalmology company SARcode Bioscience for $160 million

License agreement could have a total financial consideration of $225 million

Study reveals VEGF, often targeted and suppressed in treating wet macular degeneration, is pivotal in retina health

Air Force longitudinal study aims to prepare healthcare providers for a world rife with personal genomic information

Thanks in part to the mishandling of donated human retina during shipping, researchers have developed detailed computer simulations that enabled them to uncover a previously undetected mechanism that causes choroidal neovascularization of the macular area of the retina

Companies to co-promote EYLEA for treatment of wet AMD

Bausch + Lomb acquires ISTA, gains strong ophthalmic portfolio

Baush + Lomb to acquire ISTA Pharmaceuticals for approximately $500 million

Ophthalmic biotechnology company is dedicated to the treatment of sight-threatening diseases of the retina

Valeant shows both its amiable and hostile sides with an agreement to acquire Australia’s iNova and a hostile bid to take over U.S. company ISTA Pharmaceuticals

Proximagen, Altacor to collaborate on glaucoma treatment

Oxford BioMedica takes glaucoma research from Mayo Clinic to explosive new level with agreement to develop gene therapy